65,437 trials
Acne Vulgaris
Primary: Percent Change in Inflammatory Acne Lesion Counts From Baseline to Week 12 — -37.4; -34.7; -30.7; -44.8 Percent change
Smoking · Nicotine Dependence
Primary: Biochemically Confirmed 7-day Point Prevalence Abstinence From Tobacco — 7; 8; 6 participants — p=0.52
Fibromyalgia
Primary: Levels of Growth Hormone Post Exercise — 4.95; 1.41 ng/ml — p=<0.02
Anemia · Leukemia · Lymphoma
Primary: Hematopoietic Response Rate Defined as the Number of Participants Who Exhibit a Hematopoietic Response — 114; 109; 106; 50 Participants — p=0.39
Analgesia
Primary: Number of Participants With an Unexpected Serious Adverse Event — 0; 766 participants
Disorder Related to Cardiac Transplantation
Primary: Change in Measured Glomerular Filtration Rate (mGFR) From Baseline to Month 12 — 48.6; 48.0; 53.2; 47.5 mL/min
Peripheral Arterial Occlusive Disease
Primary: Level of Pain in the Lower Extremities Scored by the Participants on the Visual Analog Scale Following Intraarterial Administration of ISOVUE-250 or VISIPAQUE 270 in…
Labor Pain · Post-cesarean Delivery
Primary: Duration of Intrathecal Fentanyl Analgesia — 70; 63 Minutes — p=0.54
Carcinoma, Hepatocellular
Primary: Number of Participants With the Development of Hepatocellular Carcinoma (HCC) — 15; 11 Participants
Depressive Disorder
Primary: Area Under the Curve_steady-state — 996.2436; 1038.5812 ng/h/ml
Hypercholesterolemia
Primary: Fecal Excretion of Plasma-derived Cholesterol — 1593; 1950 mg/day cholesterol excreted — p=0.019
Benign Prostatic Hyperplasia · Prostatic Hyperplasia
Primary: Number of Participants With an Adverse Event — 146 participants
Cognitive and Cerebral Blood Flow Effects of Resveratrol
Primary: Modulation of Levels of Total Haemoglobin — 1.9; 2.4; 1.2 µmol/L — p=>0.05
Fractures, Bone · Type II Diabetes
Primary: Number of Low Impact Fractures in Males and Females After 6 Months of Exposure to TZD — 4325; 105; 12; 1 fractures
Constipation · Cystic Fibrosis
Primary: Number of Spontaneous Bowel Movements Per Week — 9.7; 10.8; 8.8 bowel movements